Close
Digital Health & Ai Innovation summit 2026
APE 2026

Nucletron Announced the launch of Oncentra® Simulation 2 3 for digital simulation

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Supplier Quality Management in Complex Pharma...

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

GMP Audits Driving Continuous Quality Excellence

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Digital Quality Systems Transforming Compliance Models

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.
Nucletron, a knowledge-based leader in radiation oncology, today announced the launch of Oncentra Simulation 2.3 for digital simulation and verification workflow for every Simulix. Oncentra Simulation 2.3 provides DICOM connectivity with increased efficiency and accuracy with electronic simulation. Oncentra Simulation reduces procedure times and eliminates costs associated with film processing, processing and storage. 

Nucletron, a knowledge-based leader in radiation oncology, today announced the launch of Oncentra Simulation 2.3 for digital simulation and verification workflow for every Simulix. Oncentra Simulation 2.3 provides DICOM connectivity with increased efficiency and accuracy with electronic simulation. Oncentra Simulation reduces procedure times and eliminates costs associated with film processing, processing and storage. 

Oncentra Simulation enables clinicians to easily upgrade existing or outdated systems with the advantages of proven software.  The system employs the latest imaging techniques providing high quality digital imaging, a totally filmless environment with powerful DICOM connectivity fully integrating simulation and verification into the electronic patient record.

Jos Lamers, chief executive officer of Nucletron said, Oncentra Simulation 2.3 enables both new and existing Simulix customers to fully integrate their simulator into a digital radiation therapy workflow, whilst at the same time offering significant improvements in terms of image quality and image processing capabilities.

Oncentra Simulation 2.3 was released on 20 March 2009. Oncentra Simulation in pending regulatory clearance in North America.

About Nucletron

Nucletron is a knowledge-based leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care.  Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services.  Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams – reconfiguring traditional boundaries between customer and solution provider.  Many Nucletron employees have clinical experience delivering oncology care, providing an in-depth understanding of the complex needs of clinicians.  For more information, visit http://www.nucletron.com/ .

Latest stories

Related stories

Supplier Quality Management in Complex Pharma Networks

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

GMP Audits Driving Continuous Quality Excellence

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Digital Quality Systems Transforming Compliance Models

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.

Advancing Data Integrity Across Biotech Manufacturing

Ensuring the accuracy and reliability of information is the lifeblood of biotechnology production, where even minor discrepancies in digital or physical records can compromise product safety and regulatory standing.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »